Bio-Rad Laboratories, Inc. presented on Droplet Digital PCR, highlighting its revolutionary impact on the future of PCR technology.
The presentation emphasized forward-looking statements regarding the company's goals, financial performance, and product strategy.
Bio-Rad showcased its digital PCR portfolio, illustrating its innovation and leadership in the field.
Evolution of PCR to Digital PCR
Digital PCR technology has transformed nucleic acid quantification, enabling absolute quantification and rare-event applications like liquid biopsies.
Bio-Rad's Innovation
Bio-Rad commercialized the first FDA-cleared and CE-IVD registered dPCR system, setting new standards for precision and accuracy in diagnostic tests.
Droplet Digital PCR Benefits
The droplet-based approach offers unparalleled precision, accuracy, and reproducibility, making it a benchmark in nucleic acid quantification.
- Droplet Digital PCR technology has revolutionized nucleic acid quantification, providing unprecedented levels of precision and accuracy for various applications.
- Bio-Rad's continued innovation in digital PCR has led to the development of novel tests enabling advancements in cell and gene therapy applications.
In conclusion, Bio-Rad Laboratories is at the forefront of digital PCR technology, driving the future of nucleic acid quantification with its pioneering solutions.